Related references
Note: Only part of the references are listed.Rifaximin in the treatment of recurrent Clostridium difficile infection
E. Mattila et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
Steliana Huhulescu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pharmacotherapy for Hepatic Encephalopathy
Paula V. Phongsamran et al.
DRUGS (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas
Z-D Jiang et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
High Frequency of Rifampin Resistance Identified in an Epidemic Clostridium difficile Clone from a Large Teaching Hospital
Scott R. Curry et al.
CLINICAL INFECTIOUS DISEASES (2009)
Rifampin and rifaximin resistance in clinical isolates of Clostfdium diicile
Jennifer R. O'Connor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004
David W. Hecht et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus
CK Murphy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis
U Dreses-Werringloer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial
HL DuPont et al.
CLINICAL INFECTIOUS DISEASES (2001)